10-Q
Quarterly Report
Translational Development Acquisition Corp. TDAC TDACU TDACW
0001104659-25-112494
- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$491.02K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$40.48K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $47.15K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $438.17K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$6.38M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$6.17M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$5.94M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$5.6M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$570.63K |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$509.34K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$507.66K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$507.66K |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $422.85K |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $210.3K |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $6.46M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $6.25M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $80.58K |
| Current Assets | Q3 2025 · Dec 31, 2024 | $650.23K |
| Total Assets | Q3 2025 · Sep 30, 2025 | $179.98M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $175M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $213.66K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $782.19K |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $61.28K |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $62.97K |
| Net Income | Q3 2025 · Sep 30, 2025 | $1.66M |
| Net Income | Q3 2025 · Sep 30, 2025 | $4.77M |
| Net Income | Q3 2025 · Jun 30, 2025 | $1.62M |
| Net Income | Q3 2025 · Mar 31, 2025 | $1.48M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$61.28K |
| Net Income | Q3 2025 · Sep 30, 2024 | −$62.97K |
| Net Income | Q3 2025 · Jun 30, 2024 | −$1.69K |
| Net Income | Q3 2025 · Mar 31, 2024 | $0 |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$213.66K |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$782.19K |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$61.28K |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$62.97K |